🇦🇺

Bristol-Myers Squibb makes $12 million investment in Compugen, sets up research partnership

Credit: Proactive Investors- Published 1 week ago
US pharmaceutical giant Bristol-Myers Squibb (NYSE:BMY) has agreed to make a $12 million investment in Compugen Ltd (NASDAQ:CGEN), the Israeli drug developer, as part of a new partnership between the companies, which also involves shared cancer trials. The new trials will evaluate the safety and tolerability of Compugen’s...
Advertisement

Recent related videos from verified sources

Researchers Awarded $1 Million Prize At Magee-Womens Research Summit 00:41
Credit: KDKA CBS 2 Pittsburgh - Published 2 weeks ago 


Over 1 million People Without Power After Hurricane Michael 00:32
Credit: Wochit News - Published 1 week ago 


TUI pilot absolutely nails SIDEWAYS landing in 40-knot crosswinds at Bristol Airport 01:09
Credit: Newsflare STUDIO - Published 1 week ago 


Recent related news from verified sources

Alkane Resources Ltd (ASX:ALK) has completed an investment into gold exploration company Calidus Resources Ltd (ASX:CAI) for 125 million ordinary shares at a...
4 days ago • Proactive Investors

Parkway Minerals NL’s (ASX:PWN) investment Davenport Resources Ltd (ASX:DAV) has rocketed 14% during intraday trading after upgrading the inferred resource for...
5 days ago • Proactive Investors

MMJ PhytoTech Ltd (ASX:MMJ) has an active strategy in the medicinal cannabis sector which chief executive officer Jason Conroy will outline at the Proactive CEO...
1 week ago • Proactive Investors

You might like